Skip to main content
logo
BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.2375
+0.0162 (7.32%)
At close: Aug 28, 2026

BetterLife Pharma Ratios and Metrics

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Market Capitalization
3861161014
Market Cap Growth
304.50%-49.81%77.29%-35.21%-26.56%-75.00%
Enterprise Value
4291581312
Last Close Price
0.240.040.090.060.110.16

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
PB Ratio
-8.13-1.21-2.26-1.13-1.77-4.47

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Debt / Equity Ratio
-0.15-0.14-0.18-0.07-0.02-0.08
Net Debt / Equity Ratio
-0.14-0.14-0.18-0.07-0.02-0.04
Net Debt / EBITDA Ratio
----0.16-0.02-0.01
Net Debt / FCF Ratio
-1.09-1.43-0.65-0.21-0.12-0.01
Quick Ratio
0.010.000.000.010.000.12
Current Ratio
0.040.030.030.040.010.28
Return on Assets (ROA)
-500.55%-508.19%-1074.42%-1004.42%-936.16%-493.00%
Return on Capital Employed (ROCE)
29.60%28.00%64.60%45.70%130.90%334.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Earnings Yield
-3.62%-19.10%-21.15%-33.29%-67.53%-70.08%
FCF Yield
-1.59%-7.99%-12.15%-28.49%-11.26%-64.57%
Buyback Yield / Dilution
-19.26%-17.77%-13.34%-26.25%-14.70%-179.24%